VitalHub Announces Expansion Sale of Transforming Systems’ SHREWD WaitLess Solution to Kent and Medway Clinical Commissioning Group
January 25 2022 - 7:30AM
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased
to announce a multi-year licensing sale of wholly owned subsidiary
Transforming Systems’ (“TS”) proprietary SHREWD WaitLess module to
the Kent and Medway Clinical Commissioning Group (the “CCG” or
“Kent and Medway”).
The CCG has agreed to a two-year licensing agreement for the
SHREWD WaitLess product, which empowers patients
and support system wide load-balancing through the WaitLess App. By
presenting combined live waiting times across MIUs, UTCs, WICs and
EDs and indicative travel time information across the locality,
SHREWD WaitLess provides detailed site and service information for
each location, enabling patients to make informed decisions on
where they choose to be seen.
This expansion sale stems from the CCG’s need to improve load
balancing and patient overflow across sites, to alleviate excess
pressures and over-burdened care services. Spanning four regional
areas, four trusts, and eleven centres across twenty
self-presenting sites, the CCG employs over 500 staff members, and
is responsible for serving a population nearing two million
individuals.
SHREWD WaitLess enables the public to choose their destination
for treatment by utilizing live wait time data and travel time;
combining these to give the public the quickest overall location
for treatment. This sale increases the footprint of VitalHub
products and services used across Kent and Medway, which currently
include Transforming System’s Resilience,
Action, and Region products, and
Intouch with Health products; and will help to increase
organizational efficiencies and reduce pressures across the
CCG.
“This sale is a testament to the strength of the relationship
cultivated with Kent and Medway, and the considerable value driven
from the use of our solutions,” said Dan Matlow, CEO of VitalHub
Corp. “As we begin to emerge from the COVID-19 pandemic and adjust
to a ‘new-normal’, healthcare systems are demonstrating strong
demand for digital tools that improve patient overview, and help
improve resource utilization and capacity allocation. We are
excited to deepen our relationship with Kent and Medway, as we
continue to deploy our products and services on an international
basis.”
ABOUT KENT AND MEDWAY CLINICAL
COMMISSIONING GROUP
NHS Kent and Medway Clinical Commissioning Group (“CCG”) is the
NHS organisation that plans and buys healthcare services to meet
the needs of their population. The CCG was formed in April 2020 by
bringing together eight smaller CCGs. Creating one CCG was a vital
step towards Kent and Medway becoming an integrated care
system, with health and care organizations working together much
more closely than in the past. The focus of the CCG is to deliver a
more coherent strategy for Kent and Medway, to promote consistent
healthcare outcomes, and to address inequality and inequity across
the region. The CCG has an annual budget of £3.211 billion, serves
a population of 1.8 million, and employs over 500 individuals.
ABOUT VITALHUB
Software for Health and Human Services providers designed to
simplify the user experience & optimize outcomes.
VitalHub provides technology to Health and Human Services
providers including; Hospitals, Regional Health Authorities, Mental
Health, Long Term Care, Home Health, Community and Social Services.
VitalHub solutions span the categories of Electronic Health Record
(EHR), Case Management, Care Coordination, Patient Flow &
Operational Visibility, and DOCit Mobile Apps.
The Company has a robust two-pronged growth strategy, targeting
organic growth opportunities within its product suite, and pursuing
an aggressive M&A plan. Currently, VitalHub serves 275+
clients across Canada, USA, UK, Australia, Qatar, and Latvia.
VitalHub is based in Toronto, Canada, with an offshore
development hub in Sri Lanka. The Company is publicly traded on the
TSX Venture Exchange under the symbol “VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking statements regarding
the Corporation and its business, which may include, but is not
limited to, statements with respect to the appointment of a new
directors. Often, but not always, forward-looking statements can be
identified by the use of words such as "plans", "is expected",
"expects", "scheduled", "intends", "contemplates", "anticipates",
"believes", "proposes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would", "might" or
"will" be taken, occur or be achieved. Such statements are based on
the current expectations of the management of each entity and are
based on assumptions and subject to risks and uncertainties.
Although the management of each entity believes that the
assumptions underlying these statements are reasonable, they may
prove to be incorrect. The forward-looking events and circumstances
discussed in this release, may not occur by certain specified dates
or at all and could differ materially as a result of known and
unknown risk factors and uncertainties affecting the companies,
including risks regarding the technology industry, failure to
obtain regulatory or shareholder approvals, market conditions,
economic factors, the equity markets generally and risks associated
with growth and competition. Although the Corporation has attempted
to identify important factors that could cause actual actions,
events or results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking statement can be
guaranteed. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made and the Corporation undertakes no obligation to publicly
update or revise any forward-looking statement, whether as a result
of new information, future events, or otherwise.
CONTACT INFORMATION
Dan MatlowChief Executive Officer, Director(416)
727-9061dan.matlow@vitalhub.com
Vitalhub (TSX:VHI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vitalhub (TSX:VHI)
Historical Stock Chart
From Jul 2023 to Jul 2024